| |
| |
|
| Insider
Information: |
Hutson Nancy J |
| Relationship: |
Director |
| City: |
Durham |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
212,328 |
|
|
Indirect Shares
|
5,000 |
|
|
| Direct
Value |
$469,333 |
|
|
|
Indirect Value
|
$1 |
|
|
| Total
Shares |
217,328 |
|
|
| Total
Value |
$469,333 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
6
|
1
|
|
Stock
price went up :
|
3
|
0
|
| Stock
price went down : |
3
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
 8.3%
|
 -30.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Endo Health Solutions Inc |
ENDP |
Director |
2014-02-28 |
0 |
2010-12-07 |
1,000 |
Premium* |
|
|
Biocryst Pharmaceuticals Inc |
BCRX |
Director |
2023-06-14 |
81,818 |
|
0 |
Premium* |
|
|
Phasebio Pharmaceuticals Inc |
PHAS |
Director |
2023-05-19 |
37,510 |
2023-05-19 |
4,000 |
Premium* |
|
|
Clearside Biomedical, Inc. |
CLSD |
Director |
2023-10-03 |
93,000 |
2020-05-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
52 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ENDP |
Endo Health Solutions Inc |
Director |
– • – |
2009-03-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,908 |
|
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
– • – |
2012-01-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,891 |
|
- |
|
| ENDP |
Endo Health Solutions Inc |
Director |
– • – |
2010-03-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,954 |
9,742 |
0 |
- |
|
| ENDP |
Endo Health Solutions Inc |
Director |
– • – |
2011-03-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,417 |
14,002 |
0 |
- |
|
| ENDP |
Endo Health Solutions Inc |
Director |
– • – |
2011-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
4,260 |
4,260 |
0 |
- |
|
| ENDP |
Endo Health Solutions Inc |
Director |
– • – |
2011-03-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,954 |
14,002 |
0 |
- |
|
| ENDP |
Endo Health Solutions Inc |
Director |
– • – |
2012-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
5,481 |
5,481 |
0 |
- |
|
| ENDP |
Endo Health Solutions Inc |
Director |
– • – |
2012-03-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,417 |
19,483 |
0 |
- |
|
| ENDP |
Endo Health Solutions Inc |
Director |
– • – |
2013-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
6,515 |
6,515 |
0 |
- |
|
| ENDP |
Endo Health Solutions Inc |
Director |
– • – |
2014-02-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(6,515) |
0 |
0 |
- |
|
| ENDP |
Endo Health Solutions Inc |
Director |
– • – |
2014-02-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(20,483) |
0 |
0 |
- |
|
| PHAS |
Phasebio Pharmaceuticals ... |
Director |
– • – |
2023-05-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,750 |
37,510 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2023-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
16,745 |
94,684 |
0 |
- |
|
| PHAS |
Phasebio Pharmaceuticals ... |
Director |
– • – |
2018-12-17 |
4 |
B |
$4.46 |
$4,460 |
I/I |
1,000 |
1,000 |
2.1 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2021-02-26 |
4 |
A |
$10.78 |
$4,991 |
D/D |
463 |
64,756 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2020-08-31 |
4 |
A |
$4.15 |
$4,997 |
D/D |
1,204 |
63,315 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2020-11-30 |
4 |
A |
$5.11 |
$4,998 |
D/D |
978 |
64,293 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2021-05-28 |
4 |
A |
$15.77 |
$4,999 |
D/D |
317 |
65,073 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • – |
2023-10-03 |
4 |
B |
$0.86 |
$8,600 |
D/D |
10,000 |
93,000 |
2.39 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2015-08-31 |
4 |
A |
$11.64 |
$8,742 |
D/D |
751 |
16,642 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2015-11-30 |
4 |
A |
$10.61 |
$8,743 |
D/D |
824 |
17,466 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2016-02-29 |
4 |
A |
$1.99 |
$8,748 |
D/D |
4,396 |
21,862 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2016-05-31 |
4 |
A |
$3.39 |
$8,750 |
D/D |
2,581 |
24,443 |
0 |
- |
|
| PHAS |
Phasebio Pharmaceuticals ... |
Director |
– • – |
2021-08-18 |
4 |
B |
$3.08 |
$9,240 |
I/I |
3,000 |
4,000 |
2.1 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • – |
2020-05-20 |
4 |
B |
$1.85 |
$9,250 |
D/D |
5,000 |
5,000 |
2.39 |
% |
|
52 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
